搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
1 天
on MSN
Absci Corporation (ABSI): Pioneering AI-Driven Antibody Discovery with a ‘Buy’ Rating ...
We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...
9 天
Harnessing AI and data science to discover life-changing medicines at AstraZeneca
From accelerating drug development and clinical trials to supercharging collaboration, machine learning-enhanced healthcare ...
3 天
ImmunoPrecise Antibodies develops new class of GLP-1 therapies through AI
ImmunoPrecise Antibodies (IPA) has developed a new class of GLP-1 therapies entirely through artificial intelligence, designed to enhance ...
5 天
on MSN
ImmunoPrecise Antibodies Ltd. (IPA) Launches AI-Powered Drug Discovery Pipeline ...
We recently compiled a list of the 10 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...
10 天
Scientists use AI to create completely new anti-venom proteins
Each year, snake bites kill upwards of 100,000 people and permanently disable hundreds of thousands more, according to ...
BioWorld
3 天
Immunoprecise uses AI to develop new class of GLP-1 therapies
Immunoprecise Antibodies Ltd. (IPA) has developed a new class of GLP-1 therapies entirely through AI, designed to enhance ...
Morningstar
4 天
IPA (ImmunoPrecise Antibodies) Pioneers AI-Designed GLP-1 Therapies: A Potential New ...
ImmunoPrecise Antibodies Ltd. (IPA ... and patient satisfaction in diabetes treatment. These AI-designed therapeutics aim to improve upon current GLP-1 therapies, which are widely used for ...
8 天
ImmunoPrecise Antibodies realigns pipeline strategy, AI-powered pipeline
ImmunoPrecise Antibodies (IPA) announced the launch of its AI-powered pipeline of both optimized and new therapeutics. By combining advanced ...
3 天
What's Going On With ImmunoPrecise Antibodies Stock Wednesday?
Immunoprecise shares closed higher on Wednesday after the company announced it developed a new class of GLP-1 therapies.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈